PODCAST – Talk radioisotopes: Why Astatine-211 might be the goldilocks isotope for radiopharmaceuticals
In this episode of the podcast “Talk Radioisotopes: Going Nuclear on Cancer” hosted by Nusano* our Co-Founder and CEO Milton Lönnroth shares how Atley Solutions is changing the game for astatine-211.
*‘Talk Radioisotopes: Going Nuclear on Cancer’ is brought to you by Nusano, a physics company whose breakthrough technologies are poised to help supply the fight against cancer and enable innovation across multiple industries. Join host Scott Larrivee and experts from across the industry, as they break down the science, shed light on real-world opportunities, and take a peek behind the curtain at the people, companies, and programs driving innovation in nuclear medicine.
